Stability of Short Implants Versus Standard Blx Implants With Internal Sinus Floor Elevation in Posterior Maxilla
Launched by CAIRO UNIVERSITY · Mar 10, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of short dental implants compared to standard implants in the back part of the upper jaw, especially for patients who have experienced bone loss. Bone loss can make it challenging to place implants, which are artificial tooth roots used to support crowns or bridges. The trial aims to find out if using shorter implants can be a simpler and less invasive option than traditional methods that require bone grafting or sinus lifts.
To participate in this trial, you must be at least 20 years old and have a specific type of tooth loss in the back of your upper jaw, with enough bone height (7-8 mm) and width (at least 6 mm) to support the implant. Unfortunately, smokers and those with certain health conditions or habits that could affect implant success are not eligible. If you join the study, you can expect close monitoring, and your experience will help researchers understand the best ways to improve dental implant procedures for patients with similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Single edentuolous site at maxillary posterior region
- • The available bone height below the maxillary sinus should be 7-8mm
- • Patients ≥ 20 years old
- • Bucco-palatal bone width should be ≥6mm
- • Adequate interarch space
- • Bounded, single
- Exclusion Criteria:
- • Patients with local pathological defects related to the area of interest.
- • Patients with habits that may jeopardize the implant longevity and affect the results of the study such as alcoholism or parafunctional habits.
- • Inadequate inter-arch space for implant prosthetic part
- • Smokers
- • pregnancy
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Greater Cairo, Egypt
Patients applied
Trial Officials
Hani El Nahass, Professor
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials